Results 201 to 210 of about 616,611 (358)

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Role of serum M2BPGi levels in diagnosing significant liver fibrosis and cirrhosis in patients with chronic hepatitis B [PDF]

, 2021
Marcel William Keddeas, Hany H. Kaisar, Hagar Ahmed Ahmed Elessawy, Mariam Samir Abdel Hamid Elewa   +3 more
openalex   +1 more source

Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review

Clinical Anatomy, EarlyView.
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley   +1 more source

The impact of chronic hepatitis B and chronic hepatitis C on sexual function: a systematic review and meta-analysis. [PDF]

Reprod Health
Zhang JZ, Zheng J, Zhang YP, Liu CH, Song XN, Shen YL, Tang H, Li H.   +7 more
europepmc   +1 more source

Lipid Profile Differences in HIV‐Infected Populations With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis

Chronic Diseases and Translational Medicine, EarlyView.
PRISMA study flow diagram. ABSTRACT Introduction Advances in HIV management have transformed HIV into a chronic condition, resulting in improved prognosis and increased survival among people living with HIV (PLWH). Traditional risk factors for metabolic dysfunction‐associated steatotic liver disease (MASLD)—including dyslipidemia—are prevalent in PLWH.
Yovita Hartantri, Sherly Lawrensia, Steven Yulius Usman, Nenny Agustanti, Rudi Wisaksana, Nanny Natalia Mulyani Soetedjo, Bachti Alisjahbana   +6 more
wiley   +1 more source

Hepatic Macrophages in Chronic Hepatitis B: Balancing Immunity and Pathology. [PDF]

Biology (Basel)
Pathania AS, Bhat SA, Adepoju LA, Kharbanda KK, Osna NA.   +4 more
europepmc   +1 more source

Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

, 2016
D.Yu. Konstantinov, Л. А. Попова, E Konstantinova   +2 more
openalex   +1 more source

Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B [PDF]

, 2010
Yan Liu, Chunmei Wang, Yanwei Zhong, Li Chen, Xiaodong Li, Dong Ji, Huifen Wang, Shaojie Xin, Fabien Zoulim, Dongping Xu   +9 more
openalex   +1 more source

Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling

Developmental Dynamics, EarlyView.
Abstract Background Sporadic venous malformation (VM) is associated with the hyperactivating p.L914F mutation in TIE2, a receptor tyrosine kinase essential for vascular development. This mutation is not found in hereditary VM, suggesting incompatibility with life when expressed during early vascular development.
Lindsay J. Bischoff, Sandra Schrenk, Kara Soroko, Chhiring Sherpa, Ashok Arasu, Damien Reynaud, Elisa Boscolo   +6 more
wiley   +1 more source

Steatotic liver disease in patients with chronic hepatitis C. [PDF]

World J Hepatol
Janczura J, Brzdęk M, Flisiak R, Dobrowolska K, Brzdęk K, Rzymski P, Zarębska-Michaluk D.   +6 more
europepmc   +1 more source